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Background: While colorectal cancer (CRC) screening is effective and cost-effective for reducing CRC 
incidence and mortality, it is underutilized (nearly 40% of U.S. adults are either not current with or have never 
been screened), inefficient (low-risk persons undergo colonoscopy), and costly to the U.S. health care system.  
A simple and effective way of stratifying risk for advanced neoplasia (AN – CRC and advanced, precancerous 
polyps) could improve the efficiency and uptake of screening by tailoring colonoscopy toward persons at high-
risk and giving low-risk persons less-invasive options. Although several risk factors for AN have been 
identified, they are not used in clinical practice in part because of inability to integrate the factors to produce a 
risk estimate. 
Objective: To derive and validate a risk index for AN (CRC, advanced adenomas, serrated polyps >= 1 cm) 
anywhere in the colorectum. 
Methods: We measured socio-demographic features, medical and family history, lifestyle factors, and physical 
features in 50-80 year old persons who underwent first-time screening colonoscopy between December 2004 
and September 2011, and linked these factors to endoscopic and histologic findings. Using logistic regression, 
we derived a risk equation on a randomly selected 2/3s of the sample.  A 12-variable model was selected 
based on optimal statistical metrics. Based on model coefficients, we assigned points to each variable to 
create a risk score, which ranged from -13 to 8. Scores with comparable magnitudes of risk were collapsed into 
3 risk categories. The model was tested on the remaining third of the sample. 
Results: Among 3025 subjects in the derivation set (mean age 57.3 ± 6.5 years; 52% women), the prevalence 
of AN was 9.4% (including 26 CRCs).  Model  variables include age, sex, smoking, ethanol use, marital status, 
NSAID and aspirin use, physical activity, education level, and metabolic syndrome (P-value for fit = 0.09; c-
statistic=0.78). Respective risks of AN in the low- (scores of -13 to -5), intermediate- (scores of -4 to 2) and 
high- (scores of 3 to 12) were 1.52% (95%, 0.07-2.8%), 6.86%, and 26.8% (P-value for trend < 0.001), with 
respective cohort proportions of 23%, 59% and 18%. Ten low-risk subjects had AN (0 CRCs, 6 distal). Based 
on finding a distal sentinel polyp, sigmoidoscopy to the descending colon would have detected 7(70%) ANs.  
Among the 1475 subjects in the test set (mean age 57.2 ± 6.5 years; 52% women), AN prevalence was 8.4%.  
Risk of AN in the low-risk subgroup was 2.73% (CI, 1.25-5.11%) and was 5.57% and 25.4% in the 
intermediate- and high-risk subgroups, respectively  (P<0.001), with cohort proportions of 23%, 59%, and 18%.  
Nine low-risk subjects had AN (0 CRCs, 5 distal, 6 detectable by sigmoidoscopy. 
Conclusion: This new risk index effectively stratifies the risk for AN among asymptomatic adults, identifying a 
low-risk subgroup of 23% that may be screened effectively and efficiently with tests other than colonoscopy 
and a high-risk subgroup of 18% in which colonoscopy may be preferable.  If validated in other settings, this 
index could increase both the efficiency and uptake of CRC screening. 
